REGENTIX
Covidien Ag
Application Filed: 2007-09-19
Trademark Application Details
CANCELLED - SECTION 8
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77283640 |
| Registration Number | 3684876 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | 2 |
| Domestic Representative | Mark Farber |
| Attorney Name | Mark Farber |
| Attorney Docket Number | Regentix |
| Law Office Assigned | L60 |
| Employee Name | GOLD, BARBARA A |
Timeline
| 2007-09-19 | Application Filed |
| 2009-03-31 | Published for Opposition |
| 2009-09-22 | Location: PUBLICATION AND ISSUE SECTION |
| 2009-09-22 | Trademark Registered |
| 2016-04-29 | Cancelled |
| 2016-04-29 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  COVIDIEN AG |
| Address | VICTOR VON BRUNS-STRASSE 19 8212 NEUHAUSEN AM CH 8212 |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Medical preparations for the treatment, reconstruction, recontouring, repair or augmentation of human tissue for use in general, plastic and reconstructive, urological, gynecological, orthopaedic, gastro-oesophageal, anal, colorectal and abdominal surgery; medical preparations for the treatment, reconstruction, recontouring, augmentation of human tissue formed of or using natural collagen-containing tissue materials; surgical and medical implants in injectable and non-injectable form prepared from natural collagen-containing tissues; surgical implants comprising living tissue; biological implants, namely, avital processed human or animal tissue; biological tissues, namely, skin, blood vessel, bone, ligament, tendon, nerve, gastrointestinal tract, heart, liver, kidney, pancreas, spleen, bladder, urethra and ureter tissues, intended for subsequent implantation |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2007-09-24 | 1 NWAP I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2007-11-07 | 2 TCCA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2007-12-21 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2007-12-21 | 4 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2007-12-26 | 5 CNRT F:First Action |
| PAPER RECEIVED | 2008-04-02 | 6 MAIL I:Incoming Correspondence |
| ASSIGNED TO LIE | 2008-04-03 | 7 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2008-04-03 | 8 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2008-04-03 | 9 ACEC I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2008-05-21 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION MAILED | 2008-05-22 | 11 CNSL S: |
| SUSPENSION INQUIRY WRITTEN | 2008-12-07 | 12 CNSI R:Renewal |
| INQUIRY AS TO SUSPENSION MAILED | 2008-12-08 | 13 CNSI S: |
| PAPER RECEIVED | 2009-02-02 | 14 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-02-04 | 15 CRFA I:Incoming Correspondence |
| AMENDMENT FROM APPLICANT ENTERED | 2009-02-04 | 16 ACEC I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2009-02-17 | 17 CNEA R:Renewal |
| EXAMINER'S AMENDMENT ENTERED | 2009-02-18 | 18 XAEC I:Incoming Correspondence |
| EXAMINERS AMENDMENT MAILED | 2009-02-18 | 19 CNEA O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2009-02-19 | 20 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2009-02-23 | 21 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2009-03-11 | 22 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2009-03-31 | 23 PUBO A:Allowance for Publication |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2009-04-30 | 24 ETOF T:TTAB Proceeding |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2009-07-30 | 25 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2009-07-30 | 26 ARAA I:Incoming Correspondence |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2009-08-13 | 27 ETOP T:TTAB Proceeding |
| REGISTERED-PRINCIPAL REGISTER | 2009-09-22 | 28 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2010-07-21 | 29 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2011-02-14 | 30 TCCA I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2014-04-30 | 31 ASCK I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2014-05-14 | 32 ASGN I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2016-04-29 | 33 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 REGENTIX 88366630 5874230 Live/Registered |
Norvoc Bioscience Inc. 2019-04-01 |
 REGENTIX 77283640 3684876 Dead/Cancelled |
COVIDIEN AG 2007-09-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 